Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMIM7 (Small integral membrane protein 7) is a protein-coding gene located on chromosome 19q13.33, widely expressed across human tissue[1][5][9]. The encoded protein is predicted to be a small integral membrane protein, primarily associated with membrane trafficking, but its specific biological function is not well established, and it is not classified as an ion channel, transporter, receptor, or enzyme[2][3][7]. There is currently no evidence supporting a direct role in human disease, drug interaction, or utility as a therapeutic target[3][10][11]. Its aliases include C19orf42, MGC2747, and UPF0608 protein C19orf42[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small integral membrane protein 7 (SMIM7).